Skip links

Archive

Handy Gelbard Authors STAT News Piece Touting Multi-Target Drugs

Handy Gelbard Authors STAT News Piece Touting Multi-Target Drugs

in

Precision medicine is saving lives, but Harris A. (Handy) Gelbard, director of Center for Neurotherapeutics Discovery at URMC, believes we’re overlooking another class of extremely important treatment candidates: multi-target drugs. In STAT News, he shares his views on why U.S.-based pharmaceutical companies should pay closer attention